Serina Therapeutics Inc. – Filings and Transcripts

NYSE American: SER
Share price (9/21/26): $2.31
Market cap (9/21/26): $58.7 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Initial registration of new securities

Registration of securities for employees

Shelf registration

Registration of securities for employees

Shelf registration

Ownership Filter

Juvenescence Ltd

Brannan Stephen K.

Marshall Richard Peter

News Filter

Reports Cohort 1 Observations From SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2

Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Reports Second Quarter 2026 Financial Results and Provides Business Updates

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Appoints Farrell Simon to Its Board of Directors

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness